To quantitatively compare the anti-tumor cytotoxicity of CD8+ T cells in Ero1aKO and Ero1aWT tumors, we next performed dimensionality reduction and projected each single CD8+ T cell by scoring activation, proliferation, and degranulation levels. The gene discussed is CD8A; the disease is neoplasm.